Fmoc-PEG12-NHS ester

CAS No. 2227246-92-4

Fmoc-PEG12-NHS ester ( —— )

Catalog No. M26962 CAS No. 2227246-92-4

Fmoc-PEG12-NHS ester is a PEG-based PROTAC linker that can be used to synthesize PROTACs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 Get Quote
10MG 58 Get Quote
25MG 115 Get Quote
50MG 192 Get Quote
100MG 305 Get Quote
500MG 712 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Fmoc-PEG12-NHS ester
  • Note
    Research use only, not for human use.
  • Brief Description
    Fmoc-PEG12-NHS ester is a PEG-based PROTAC linker that can be used to synthesize PROTACs.
  • Description
    Fmoc-PEG12-NHS ester is a PEG-based PROTAC linker that can be used to synthesize PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2227246-92-4
  • Formula Weight
    937.0
  • Molecular Formula
    C46H68N2O18
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)OCC1c2ccccc2-c2ccccc12)ON1C(=O)CCC1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Blake DA, McLean NV. A colorimetric assay for the measurement of D-glucose consumption by cultured cells. Anal Biochem. 1989 Feb 15;177(1):156-60.
molnova catalog
related products
  • DORA-22

    DORA-22 is a dual orexin receptor antagonist, improves mild stress-induced insomnia with minimal effect on memoryDORA-22, a dual orexin receptor antagonist, improves mild stress-induced insomnia with minimal effect on memory.

  • S1PR1 modulator 1

    S1PR1 modulator 1 is a selective inhibitor of S1PR1 with a pIC50 of 7.6.

  • Lenacapavir

    Lenacapavir is a potent capsid-targeting inhibitor of HIV replication. Lenacapavir shows anti-HIV activity with an EC50 of 100 pM in MT-4 cells.